glp-1 rich foods Promoting GLP-1 medications and protein ingredients

Incalza MA, DOria R, Natalicchio A, Perrini S, Laviola L, Giorgino F

Pharmaceutical Executive: How do you see the FDAs intent to take action against non-FDA-approved GLP-1 products affecting the competitive landscape for obesity and diabetes therapies in the near term

This activation facilitates the synthesis and secretion of various inflammatory factors by epidermal and dermal cells, including interleukin-1 (IL-1), interleukin-6 (IL-6), cyclooxygenase-2, and tumor necrosis factor-alpha (TNF-), which collectively induce inflammatory responses (85, 86)

J Clin Pharmacol 54 , 10791092, (2014)

If the next dose is less than 2 days away, skip the missed one